pI: 8.5662 |
Length (AA): 496 |
MW (Da): 55351 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127601)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G08530 | NADH dehydrogenase [ubiquinone] flavoprotein 1 |
Brugia malayi | Bm1_14150 | NADH-ubiquinone oxidoreductase 51 kDa subunit, mitochondrial precursor |
Candida albicans | CaO19.11971 | potential mitochondrial NADH-Ubiquinone Oxidoreductase Complex I subunit similar to Y.lipolytica NUBM subunit and N. crassa and |
Candida albicans | CaO19.4495 | potential mitochondrial NADH-Ubiquinone Oxidoreductase Complex I subunit similar to Y.lipolytica NUBM subunit and N. crassa and |
Caenorhabditis elegans | CELE_C09H10.3 | Protein NUO-1 |
Dictyostelium discoideum | DDB_G0288875 | NADH dehydrogenase ubiquinone flavoprotein 1 |
Drosophila melanogaster | Dmel_CG11423 | CG11423 gene product from transcript CG11423-RA |
Drosophila melanogaster | Dmel_CG9140 | CG9140 gene product from transcript CG9140-RA |
Escherichia coli | b2284 | NADH:ubiquinone oxidoreductase, chain F |
Echinococcus granulosus | EgrG_000366000 | NADH dehydrogenase ubiquinone flavoprotein 1 |
Echinococcus multilocularis | EmuJ_000366000 | NADH dehydrogenase (ubiquinone) flavoprotein 1 |
Homo sapiens | ENSG00000167792 | NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa |
Leishmania braziliensis | LbrM.05.0980 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Leishmania donovani | LdBPK_050980.1 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Leishmania infantum | LinJ.05.0980 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Leishmania major | LmjF.05.0980 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Leishmania mexicana | LmxM.05.0980 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Loa Loa (eye worm) | LOAG_00610 | NADH-ubiquinone oxidoreductase 51 kDa subunit |
Mus musculus | ENSMUSG00000037916 | NADH dehydrogenase (ubiquinone) flavoprotein 1 |
Mycobacterium tuberculosis | Rv3150 | Probable NADH dehydrogenase I (chain F) NuoF (NADH-ubiquinone oxidoreductase chain F) |
Mycobacterium ulcerans | MUL_2464 | NADH dehydrogenase I subunit F |
Oryza sativa | 4344095 | Os07g0645400 |
Onchocerca volvulus | OVOC3818 | NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial homolog |
Schistosoma japonicum | Sjp_0049230 | ko:K03942 NADH dehydrogenase (ubiquinone) flavoprotein 1, putative |
Schistosoma mansoni | Smp_010710 | NADH-ubiquinone oxidoreductase |
Schmidtea mediterranea | mk4.000692.02 | NADH dehydrogenase |
Trypanosoma brucei gambiense | Tbg972.5.450 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Trypanosoma brucei | Tb927.5.450 | NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial |
Trypanosoma brucei | Tb11.v5.0222 | NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, putative |
Trypanosoma congolense | TcIL3000_5_70 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.508399.10 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.507869.10 | NADH-ubiquinone oxidoreductase, mitochondrial, putative |
Trichomonas vaginalis | TVAG_133030 | NADH-ubiquinone oxidoreductase flavoprotein, putative |
Trichomonas vaginalis | TVAG_188080 | NADH-ubiquinone oxidoreductase flavoprotein, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0474 | NADH dehydrogenase I subunit F |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3202 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.5.450 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.450 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.450 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.450 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2284 | Escherichia coli | non-essential | goodall |
CELE_C09H10.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C09H10.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C09H10.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C09H10.3 | Caenorhabditis elegans | sterile | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Bos taurus | Mitochondrial complex I; NADH oxidoreductase | Compounds | References |
Homo sapiens | NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa | Compounds | References |